Retail News

Nearly $300 million in crypto positions were liquidated over the past 24 hours, with long traders accounting for most losses.

The travel company expects 2026 revenue of between $15.6 billion and $16 billion.

TD Cowen and Baird lowered McDonald’s price targets following the first-quarter earnings.

One influencer warned that shareholders could face “permanent economic leakage” if Tesla ends up paying SpaceXAI for AI services.

Innodata increased its full-year 2026 revenue growth forecast to around 40% or more.

Traders are also watching the FDA review of ImmunityBio’s resubmitted Anktiva plus BCG filing for non-muscle invasive bladder cancer with papillary tumors.

A hantavirus outbreak aboard a cruise ship has resulted in three deaths and raised global health concerns.

Inovio is the most direct hantavirus play based on earlier DNA vaccine studies targeting Andes, Hantaan, and Puumala strains.

Datadog is also on track to be the top gainer this week on the Nasdaq 100 and the second-best performer on the S&P 500.

Wall Street expects another loss-making quarter, with Koyfin estimates projecting EPS loss to widen to $0.06 from $0.05.

Weak earnings, lower outlooks, and rising costs show middle-class consumers are spending less on food and fitness services broadly.

The latest move by Amazon adds pressure on Hims, which already offers branded GLP-1 drugs including Wegovy, Ozempic and Zepbound.

The company forecast Q2 revenue of at least $750 million, below analyst estimates of $770.41 million.

Capricor is seeking court approval to pursue an alternative commercialization path for Deramiocel and wants parts of the agreement terminated.

During the first quarter, Iovance posted a 45% increase in revenue to $71.4 million, which came in below Wall Street’s estimates of $75.6 million, according to Fiscal.ai data.

SharpLink Gaming CEO Joseph Chalom said at Consensus Miami 2026 that the bear case for crypto and Ethereum is now “very small” due to accelerating institutional adoption.

Wall Street analysts raised their price targets on HUT’s stock following the company’s announcement of a $10 billion AI data center lease in Texas.

Tom Lee’s comments come after Strategy paused its Bitcoin accumulation last week, and executive chairman Michael Saylor said that the company might even sell some of its BTC holdings.

Kala Bio said it will implement a 1-for-50 reverse stock split, effective after the closing bell on May 8.

The statement comes after Saylor said Bitcoin sales could be used to pay dividends or optimize Strategy’s balance sheet during the company’s first quarter earnings call.

Atara said it made progress with the FDA on a potential path to resubmitting the biologics license application for its immunotherapy Tabelecleucel.

Bitwise announced on Thursday it will take over management of the $267 million Superstate Crypto Carry Fund starting June 1.

Retail traders on Stocktwits debated whether Michael Saylor may eventually sell Bitcoin holdings after comments during the company’s earnings call.

ImmunityBio posted a first-quarter revenue beat due to surging Anktiva sales.

The surge in ETF demand comes after spot Bitcoin ETFs recorded $2.44 billion in inflows during April, their strongest monthly performance since October 2025.

Spot gold and silver edged higher for a third straight session as analysts tie de-escalation reports from the Middle East to the price bump.

Dogecoin and Ethereum led losses among major cryptocurrencies, falling 4.2% and 3.6%, respectively.

AGL shares were in focus on Thursday after receiving bullish brokerage calls following a full-year 2026 guidance raise.

Analysts expect Peloton to report a third-quarter revenue of $617.76 million with an earnings per share of $0.07.

The German lender disclosed holdings of 683,420 SOUN shares valued at $4.7 million as of March 31, up 7% from the previous quarter.

The Anktiva decision is looming amid growing controversy around leadership inside the FDA’s biologics and cancer divisions.

The company raised its fiscal 2026 revenue outlook to $1.7 billion-$1.76 billion.

DoorDash sees second-quarter Marketplace Gross Order Value between $32.4 billion and $33.4 billion.

The company spotlighted new data showing that its COVID vaccine, Nuvaxovid, produced “statistically fewer side effects” than Moderna’s mNEXSPIKE vaccine.

UBS cut its Nio stake by nearly 50% during the first quarter to 12.35 million shares valued at $74.45 million.

Cohen posted screenshots on X showing that eBay had suspended his account, saying his activity was potentially risky to its community.

The American Federation of Teachers urged the SEC to apply “extraordinary scrutiny” to the IPO.

The auto insurer’s first-quarter net income nearly doubled to $35.9 million.

Intel rose on a possible Apple deal, AMD jumped on strong results, and Micron surged past a $700 billion market valuation.

Musk also claimed he could “probably end up paying trillions in taxes” due to stock-option and estate taxes.

The company sees second-quarter revenue in the $60 million to $65 million range.

ASTS said 32 next-gen satellites are already at advanced stages of assembly.

The LinkedIn co-founder said that cryptographic proofs and decentralized systems offer advantages over traditional infrastructure.

Zach Witkoff echoes Tether CEO’s “trillions of agents” vision for future crypto transactions.

The debate has been influenced by concerns over President Donald Trump’s crypto-related business interests.

MannKind is developing a dry powder inhalation version of a drug to treat pulmonary arterial hypertension.

Wall Street remained divided, with BTIG raising its MSTR price target to $350 while Benchmark cut its target to $570, though both firms maintained a ‘Buy’ rating on the shares.

Core Scientific stock rose more than 10% to hit a record high of over $25 on Wednesday, following its Oklahoma expansion announcement.

Ernexa’s ERNA-101 achieved complete tumor clearance and 100% long-term survival in syngeneic ovarian cancer models.